Integra LifeSciences Enrolls 100th Participant In Its AERA Pediatric Registry Observational Registry
Integra LifeSciences (Nasdaq: IART), a leading global medical technology company, announced today the enrollment of the 100th patient in the AERA® Pediatric Registry, a prospective, multicenter observational registry
Integra LifeSciences just signed up its 100th child patient in a medical research study. When a company builds a good research project, it shows they are serious about helping people.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.